Therapeutics
JAMA Network
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial
JAMA Network
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
Randomized Clinical Trial
JAMA Network
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
JAMA Network
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19The CoDEX Randomized Clinical Trial
JAMA Network
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19A Randomized Clinical Trial
JAMA Network
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis
JAMA Network
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
JAMA Network
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
New England Journal of Medicine
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
JAMA Cardiology
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers
JAMA
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?
Lancet
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.
Annals of Internal Medicine
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
Annals of Internal Medicine
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
International Journal of Antimicrobial Agents
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
International Journal of Antimicrobial Agents
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.
Bioscience Trends
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
Journal of Critical Care
A systematic review on the efficacy and safety of chloroquine for the treatment.
NEJM
SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers During the COVID-19 Pandemic
JAMA Network